Combination treatment of non-segmental vitiligo with a 308-nm xenon chloride excimer laser and topical high-concentration tacalcitol: a prospective, single-blinded, paired, comparative study

J Am Acad Dermatol. 2011 Aug;65(2):428-430. doi: 10.1016/j.jaad.2010.12.007.

Authors

Sang Ho Oh¹, Taegyun Kim¹, Hyunjung Jee¹, Jeong Eun Do¹, Ju Hee Lee²

Affiliations

¹ Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.
² Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. Electronic address: juhee@yuhs.ac.

PMID: 21763570
DOI: 10.1016/j.jaad.2010.12.007

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Administration, Topical
Adolescent
Adult
Anti-Inflammatory Agents / therapeutic use
Combined Modality Therapy
Dihydroxycholecalciferols / therapeutic use*
Esthetics
Female
Humans
Lasers, Excimer / therapeutic use*
Low-Level Light Therapy / methods*
Male
Middle Aged
Patient Satisfaction
Prospective Studies
Risk Assessment
Single-Blind Method
Treatment Outcome
Vitiligo / pathology*
Vitiligo / therapy*
Young Adult

Substances

Anti-Inflammatory Agents
Dihydroxycholecalciferols
1 alpha,24-dihydroxyvitamin D3